In recent years, significant strides have been made in the field of cancer diagnosis. One notable advancement is the use of liquid biopsies, which analyze circulating tumor DNA (ctDNA) in the blood. This non-invasive technique allows for early detection of cancer and monitoring of treatment response. Additionally, Artificial Intelligence (AI) and machine learning algorithms are being integrated into diagnostic imaging to improve the accuracy of detecting tumors through MRI and CT scans.
